Tag: Phase 3 study
January 29, 2020
Intercept Completes Phase 3 Enrollment of Cirrhosis Treatment
Intercept has completed patient enrollment in its Phase 3 study evaluating obeticholic acid for the treatment of cirrhosis due to... January 14, 2020
Alexion Confirms Planned Phase 3 Study of ALS Treatment
Alexion announced that is plans to start a Phase 3 study of ULTOMIRIS (ravulizumab) in amyotrophic lateral sclerosis (ALS). October 11, 2019
RedHill Biopharma Releases Positive Results from MAP US Phase 3 Study
The company announced positive results from its MAP US Phase 3 Study and MAP US2 Open-Label Extension Study August 22, 2019
Retrophin Announces Topline Results from Phase 3 FORT Study
Retrophin (NASDAQ:RTRX) has announced that the Phase 3 FORT study evaluating the safety and efficacy of fosmetpantotenate compared to a... May 9, 2018
Foamix Reports First Quarter 2018 Financial Results and Provides Corporate Update
Foamix Pharmaceuticals (NASDAQ:FOMX) a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs...
April 29, 2018
5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent
Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 26, 2018